澳大利亚警告GLP-1药物可能导致抑郁症和自杀性想法;对使用避孕措施持谨慎态度。 Australia warns GLP-1 drugs may cause depression and suicidal thoughts; caution on contraception use.

澳大利亚的药物监管者TGA(TGA)发布了有关GLP-1(GLP-1)药物(如Ozempic和Mounjaro)的安全警报,警告他们可能与自杀思想、抑郁症和情绪变化有联系。 Australia’s drug regulator, the TGA, has issued a safety alert about GLP-1 drugs like Ozempic and Mounjaro, warning of possible links to suicidal thoughts, depression, and mood changes. 敦促患者在心理健康恶化时与医生联系。 Patients are urged to contact their doctor if they experience mental health worsening. 由于有效性可能降低,TGA还建议那些使用口服避孕药的人在开始或增加剂量后四周内使用非口服或屏障方法。 The TGA also advises those using oral contraceptives to use non-oral or barrier methods for four weeks after starting or increasing the dose, due to potential reduced effectiveness. 这些药物不应在怀孕期间使用,有生育潜力的个人必须使用有效的避孕措施。 These drugs should not be used during pregnancy, and individuals of childbearing potential must use effective contraception.